WHO Issues Guidelines for Ethical Use of AI in Health Care
The World Health Organization (WHO) has released new guidelines aimed at curbing the improper use of artificial intelligence (AI) in the healthcare sector. The guidelines specifically address the ethical use of generative AI, which can generate text and images. While this technology has gained popularity in various industries, including healthcare, the WHO recognizes the need to prevent potential harm to patients and improve healthcare experiences. The guidelines comprise more than 40 recommendations for the ethics and governance of large multimodal models (LMMs), which allow generative AI to create content from different sources such as text, videos, sounds, and images.
The Risks of Generative AI in Health Care Highlighted by WHO
Although generative AI and LMMs have demonstrated benefits in healthcare, the WHO warns of potential risks and challenges associated with their use. One critical concern is the production of false, inaccurate, or incomplete information by these AI models. This can occur due to biased or poor-quality data used to train the models. Therefore, the WHO stresses the importance of engagement and collaboration between various stakeholders, including tech companies, healthcare providers, governments, and patients. By working together, it is possible to address and mitigate these risks effectively.
Governments Urged to Regulate AI in Health Care, Says WHO
The WHO emphasizes the need for government involvement in regulating AI technologies, particularly in the healthcare sector. The guidelines recommend that governments invest in not-for-profit or public infrastructure related to generative AI. These investments should ensure accessibility to technology and data while adhering to ethical principles. Furthermore, the WHO urges governments to align AI regulation with policies related to human rights, including patients’ dignity, autonomy, and privacy. The guidelines propose the establishment of regulatory agencies responsible for approving LMMs and healthcare apps, making auditing and impact assessment by independent third parties mandatory.
Transparency and Accountability Key in AI Development, WHO Advises
Transparency and accountability are crucial when developing and deploying AI solutions in healthcare, according to the WHO guidelines. The WHO stresses the importance of transparent development and design processes, which allow for the identification of ethical issues and the raising of concerns. Furthermore, the guidelines propose the publication of assessments and audits conducted by independent third parties. These assessments should be separated by patient demographics, ensuring accountability and fairness in AI-driven healthcare practices.
Pennsylvania Gov. Collaborates with OpenAI for AI Testing in Government
The interest in generative AI extends beyond the healthcare industry. Pennsylvania Governor Josh Shapiro recently signed an agreement with OpenAI to test their ChatGPT product for government use. This collaboration aims to explore the potential applications of AI in government business. Starting with a test group of 50 employees, the partnership seeks to leverage the capabilities of generative AI to enhance government operations. This initiative aligns with Governor Shapiro’s efforts to establish an AI governing board in September, further guiding the state’s use of AI technology.
The WHO’s guidelines for the ethical use of AI in healthcare underscore the importance of responsible and accountable AI development. By addressing the risks, involving governments, and encouraging transparency, the guidelines aim to ensure the safe and beneficial integration of AI in healthcare practices. Additionally, the collaboration between Pennsylvania Governor Josh Shapiro and OpenAI highlights the growing interest in generative AI across various sectors, beyond healthcare, and the potential for AI to transform government operations.
Analyst comment
Positive news: The WHO has issued guidelines for the ethical use of AI in healthcare, addressing potential risks and emphasizing transparency and accountability. This will ensure the safe integration of AI in healthcare practices. The collaboration between Pennsylvania Governor Josh Shapiro and OpenAI further highlights the growing interest in generative AI, which has potential to transform government operations.
Market impact: The guidelines and collaboration indicate increasing adoption and regulation of AI in healthcare and other sectors. This will drive demand for AI technologies and solutions, benefiting companies in the AI industry. Additionally, governments’ involvement and investment in AI infrastructure will create new opportunities for tech companies.
